Clicky

Suzhou Zelgen Biopharmaceuticals Co Ltd(688266)

Description: Suzhou Zelgen Biopharmaceuticals Co., Ltd. researches and develops, manufactures, and sells medicines in the People's Republic of China. It offers small molecule and recombinant protein drugs for the treatment of liver cancer, non-small cell lung cancer, colorectal cancer, thyroid cancer, nasopharyngeal carcinomas, myelofibrosis, hemorrhage, and hepatobiliary diseases. The company was founded in 2009 and is based in Kunshan, the People's Republic of China.


Keywords: Cancer Biopharmaceutical Life Sciences Non Small Cell Lung Cancer Colorectal Cancer Thyroid Liver Cancer Thyroid Cancer Kunshan Myelofibrosis Treatment Of Liver Cancer Hepatobiliary Diseases

Home Page: www.zelgen.com

No. 209, Chenfeng Road
Kunshan, 215300
China
Phone: 86 512 5701 8310


Officers

Name Title
Mr. Zelin Sheng Chairman & GM
Mr. Gang Huang CFO & Deputy GM
Ms. Zeqi Sheng Chief Scientific Officer
Ms. Huiping Lu Exec. Deputy GM & Director
Mr. Jisheng Wu Director & Deputy GM
Mr. Binhua Lv Deputy Gen. Mang. & Director
Ms. Qingping Gao Deputy GM & Board Sec.

Exchange: SHG

Country: CN : China

Currency: Renminbi (¥)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 12.1238
Price-to-Sales TTM: 35.4273
IPO Date:
Fiscal Year End: December
Full Time Employees: 688
Back to stocks